Skip to the page

Data / Drug companies / Iron Chelator

Iron Chelator drugs: 4 drugs from 30 companies in the FDA NDC directory

Iron Chelator is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 113 products in this class from 30 companies, covering 4 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on August 12, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 30Companies
  • 113Products
  • 4Drugs by generic name

Drugs in the Iron Chelator class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Deferasirox9121
Deferoxamine mesylate96
Deferiprone105
Deferasirox oral31

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Novartis Pharmaceuticals Corporation10tablet, film coated; tablet, for suspensionNew drug applications (NDA)May 18, 2017
Ascend Laboratories, LLC9tablet, film coated; tablet, for suspensionGeneric drugs (ANDA)July 16, 2020
Alembic Pharmaceuticals Inc.6tablet, for suspension; tablet, film coatedGeneric drugs (ANDA)June 15, 2020
Alembic Pharmaceuticals Limited6tablet, for suspension; tablet, film coatedGeneric drugs (ANDA)June 15, 2020
Aurobindo Pharma Limited6granule; tablet, film coatedGeneric drugs (ANDA)September 8, 2025
Camber Pharmaceuticals, Inc.6granule; tablet, film coatedGeneric drugs (ANDA)March 16, 2023
Dr. Reddy's Laboratories Inc.6tablet; tablet, for suspensionGeneric drugs (ANDA)June 25, 2020
MSN Laboratories Private Limited6tablet, for suspension; tabletGeneric drugs (ANDA)June 16, 2020
Novadoz Pharmaceuticals LLC6granule; tablet, for suspensionGeneric drugs (ANDA)May 21, 2022
Amneal Pharmaceuticals NY LLC3tablet, film coatedGeneric drugs (ANDA)June 15, 2020
Bionpharma Inc.3tablet, for suspensionGeneric drugs (ANDA)September 28, 2018
Chiesi USA, Inc.3solution; tabletNew drug applications (NDA)May 19, 2020
Cipla USA Inc.3granuleGeneric drugs (ANDA)February 23, 2022
Epic Pharma, LLC3granuleGeneric drugs (ANDA)October 6, 2022
Glenmark Pharmaceuticals Inc., USA3tablet, for suspensionGeneric drugs (ANDA)January 6, 2020
NorthStar RxLLC3tablet, film coatedGeneric drugs (ANDA)October 16, 2023
Sun Pharmaceutical Industries, Inc.3tablet, for suspensionGeneric drugs (ANDA)December 2, 2019
Teva Pharmaceuticals, Inc.3tablet, for suspensionGeneric drugs (ANDA)November 1, 2024
Xiromed, LLC3tabletGeneric drugs (ANDA)June 15, 2020
Zydus Lifesciences Limited3tablet, film coatedGeneric drugs (ANDA)June 16, 2020
Zydus Pharmaceuticals USA Inc.3tablet, film coatedGeneric drugs (ANDA)June 16, 2020
Apotex Corp.2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 5, 2021
AvKARE2tabletGeneric drugs (ANDA)August 12, 2026
Dr. Reddy's Laboratories Inc.2tablet, coatedGeneric drugs (ANDA)December 15, 2025
Fresenius Kabi USA, LLC2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 15, 2009
Gland Pharma Limited2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)October 9, 2017
Hikma Pharmaceuticals USA Inc.2tablet, coatedGeneric drugs (ANDA)February 8, 2022
Sun Pharmaceutical Industries, Inc.2tabletGeneric drugs (ANDA)February 5, 2024
Hospira, Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)March 31, 2005
Mitem Pharma1injection, powder, for solutionNew drug applications (NDA)April 2, 1968

Dosage forms

Dosage formProductsShare
Tablet, for suspension3329.2%
Tablet, film coated3127.4%
Granule2118.6%
Tablet1412.4%
Injection, powder, lyophilized, for solution87.1%
Tablet, coated43.5%
Injection, powder, for solution10.9%
Solution10.9%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.